Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

46 clinical studies listed.

Filters:

Hearing Loss, Sensorineural

Tundra lists 46 Hearing Loss, Sensorineural clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07949643

Operator-Assisted Oscilla Audiometry as a Basis for Hearing Aid Fitting (The Oscilla Validation Study)

The purpose of this study is to find out whether hearing tests performed with the Oscilla A60 audiometer, where the patient largely tests themselves with minimal staff assistance, are accurate enough to be used for diagnosing hearing loss and as the sole basis for fitting hearing aids. Adults referred for their first hearing aids at Aalborg University Hospital will have their hearing tested both with the Oscilla audiometer and by a trained audiology assistant at the same visit. Participants are then randomly assigned to receive hearing aids fitted based on either the Oscilla hearing test or the audiology assistant's hearing test. The main questions are: (1) Do the Oscilla results agree with the audiology assistant's results for both air-conduction and bone-conduction hearing thresholds? (2) Do participants fitted based on the Oscilla test report a hearing benefit that is not worse than that of participants fitted based on the standard test, two months after fitting?

Gender: All

Ages: 18 Years - Any

Updated: 2026-11-19

Hearing Loss, Sensorineural
Presbyacusis
COMPLETED

NCT06176625

Sight and Hearing Investigation Into Effects on Delirium

The goal of this observational study is to learn about sensory loss in hospital patients with delirium. The main questions it aims to answer are: * Are hearing and vision loss related to increased risk of having delirium? * Do hearing and vision loss contribute to more severe delirium? * Do sensory loss and/or delirium affect patient satisfaction with hospital care? Participants will be asked to: * answer delirium screening questions, * undergo hearing \& vision screenings, and * complete questionnaires about the hospital stay. The second part of this study is a clinical trial. Researchers will compare different hospital units to see if changing communication affects the number of patients with delirium. The main questions it aims to answer are: • Does sharing information about communication and/or providing hearing devices change the number of hospital patients with delirium? Participants in the study will be asked to complete delirium screenings and answer questions about their hearing and communication.

Gender: All

Ages: 65 Years - Any

Updated: 2026-11-18

1 state

Hearing Loss
Hearing Loss, Age-Related
Hearing Disability
+14
NOT YET RECRUITING

NCT07944287

NeuroSync Auditory-Cognitive Training for Listening in Noise in Hearing Aid Users

The goal of this clinical trial is to learn whether NeuroSync (Turkish: Nörosenkron), a 6-week, home-based, web-delivered auditory-cognitive training program, improves listening in noise in adults aged 18 to 65 years who use hearing aids in both ears for sensorineural hearing loss. The main questions it aims to answer are: * Does NeuroSync training improve speech understanding in noise, measured with the Turkish Hearing in Noise Test (HINT)? * Does NeuroSync training reduce listening effort, measured with a dual-task test? Researchers will compare NeuroSync training with an active control condition (watching "how-to" videos on the same web platform) to see whether the training leads to greater improvement. Participants will: * Be assigned by chance to the NeuroSync training group or the video (active control) group * Complete 4 sessions per week for 6 weeks at home (24 sessions, each up to 30 minutes), while continuing their usual daily hearing aid use * Visit their hearing aid center before and after the 6-week period for hearing, listening-in-noise, and listening-effort tests and a questionnaire

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-11-18

Hearing Loss, Sensorineural
Hearing Loss, Bilateral
ENROLLING BY INVITATION

NCT04161261

Minimizing Facial Nerve Stimulation in Cochlear Implants

This study aims to understand how to manipulate the electrical stimulation from the cochlear implant to maximize hearing stimulation and minimize facial stimulation. It is know from animal data that the hearing and facial nerves have different sensitivities to things like electrical pulse shape, its pattern, and its duration. It is very unclear however if this applies to human cochlear implant patients, and what the optimal parameters are to selectively stimulate the hearing nerve in humans. The outcomes of this study will be used to more selectively program some patients with severe facial nerve cross stimulation and to inform the development of new types of implant stimulation.

Gender: All

Ages: 18 Years - Any

Updated: 2026-11-12

Cochlear Hearing Loss
Hearing Loss, Sensorineural
Hearing Loss
+2
COMPLETED

NCT05776459

Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)

The purpose of this Phase 2 clinical trial is to evaluate the safety, tolerability and efficacy of AC102 administered as single intratympanic injection compared to oral steroid treatment in patients with Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL).

Gender: All

Ages: 18 Years - 85 Years

Updated: 2026-11-04

Hearing Loss, Sensorineural
RECRUITING

NCT06499805

Barriers and Facilitators to OTC Hearing Aids Success

Hearing aids can improve hearing, communication, and overall quality of life for people with hearing loss. However, not many people use hearing aids. A common reason is that hearing aids are expensive and hard to get. The traditional way to get hearing aids involves multiple visits to licensed audiologists for identifying hearing loss, customizing the aids, and ongoing maintenance. This traditional method is called the AUD pathway. Over-the-counter (OTC) hearing aids offer a different approach. They aim to make hearing aids more affordable and accessible, encouraging earlier use. In the OTC pathway, users diagnose their own hearing loss and fit and program the hearing aids themselves. Little is known about long-term effects of OTC hearing aids on users. This study aims to compare the experiences of people who choose the OTC pathway with those who choose the AUD pathway. It takes place in two locations: Iowa City, IA, and Nashville, TN. Participants, who have mild-to-moderate hearing loss, choose their preferred pathway and are followed for 12 months. In the OTC pathway, participants buy their hearing aids directly from OTC companies or retailers. In the AUD pathway, prescription hearing aids and fitting services are provided by audiology clinics at the University of Iowa and Vanderbilt University Medical Center. Participants are contacted 1, 6, and 12 months after starting to use their hearing aids. Researchers measure their satisfaction about hearing aids and other outcomes. If participants stop using their hearing aids, researchers assess their engagement with post-amplification hearing care. The results from both pathways are then compared.

Gender: All

Ages: 18 Years - 89 Years

Updated: 2026-11-02

2 states

Hearing Loss, Sensorineural
Presbycusis
ACTIVE NOT RECRUITING

NCT04506853

Single-Sided Deafness and Asymmetric Hearing Loss

The purpose of the study is to evaluate the long-term safety and effectiveness of cochlear implantation of the approved population in adults and children with single-sided deafness and asymmetric hearing loss.

Gender: All

Ages: 5 Years - Any

Updated: 2026-10-20

5 states

Hearing Loss, Unilateral
Hearing Loss, Sensorineural
ACTIVE NOT RECRUITING

NCT04707885

Clinical Utility of Residual Hearing in the Cochlear Implant Ear

The current study is a randomized multi-center clinical trial that investigates the role an intraoperative hearing monitoring system (electrocochleography) has on helping to save residual hearing in patients undergoing cochlear implantation (CI).

Gender: All

Ages: 18 Years - 79 Years

Updated: 2026-10-20

5 states

Hearing Loss, Sensorineural
Hearing Loss
Hearing Loss, Bilateral
COMPLETED

NCT06424262

Performance and Hearing-related Outcomes in Adults Implanted With the CI622D Dexamethasone-eluting Cochlear Implant Compared to Those Implanted With a Standard Cochlear Implant (CI622)

This clinical study will test a newly developed cochlear implant known as CI622D. This experimental cochlear implant has been designed to slowly release a drug called dexamethasone. Dexamethasone works to ease inflammation, which is common after any surgical procedure. The goal is to learn if there are added benefits in implant performance and hearing outcomes with the dexamethasone-releasing cochlear implant (CI622D) vs. the standard cochlear implant (CI622) without dexamethasone. The study will be conducted in adults with sensorineural hearing loss, a type of hearing loss caused by damage to the inner ear or auditory nerve. The study participants will undergo a series of tests that include testing their implant and their hearing. They will also complete questionnaires to see how they rate their hearing ability and their overall general health.

Gender: All

Ages: 18 Years - Any

Updated: 2026-10-08

4 states

Hearing Loss, Bilateral Sensorineural
Hearing Loss, Sensorineural
Hearing Loss, Bilateral
+1
COMPLETED

NCT07500311

Comparison of Performance Using MED-EL Automatic Sound Management

This study will evaluate the speech perception ability of adult cochlear implant users in background noise using various MED-EL Automatic Sound Management (ASM) features.

Gender: All

Ages: 18 Years - Any

Updated: 2026-10-08

1 state

Hearing Loss, Sensorineural
Cochlear Implantation
RECRUITING

NCT06516575

Listening Effort in Cochlear Implant Users

People with hearing loss experience extra effort when listening, which can lead to severe psychological barriers to communication and social participation. Listening effort can lead to fatigue, mental strain, burnout, medical sick leave, and the need for increased time to recover from regular daily activities. This proposal aims to understand effort changes on a moment-to-moment basis during listening, how long the effort lasts, and how the planning and execution of effort is impacted by the experience of using a cochlear implant.

Gender: All

Ages: 18 Years - 75 Years

Updated: 2026-08-25

1 state

Auditory Perception; Abnormal
Hearing Loss, Sensorineural
Hearing Loss
COMPLETED

NCT05558514

Place-based Cochlear Implant Mapping

The current standard of care approach for programming cochlear implants uses a generalized pitch-map for all patients. This approach fails to account for individualized inner ear anatomy. As a result, many cochlear implant recipients experience place-pitch mismatch. We have recently developed an automated mathematical tool to produce patient-specific, customized cochlear implant pitch-maps (Helpard et al., 2021). In this study, cochlear implant recipients will be randomized to receive either the clinical default pitch-map (the control group) or a place-based pitch-map (the intervention group). Assessments will be conducted at multiple time-intervals to account for patient acclimation and plasticity to both the generalized and individualized pitch-maps. Audiological assessments will be tuned to identify patients' ability to discern pitch scaling and variation in sounds, as well as to understand complexities in speech such as mood and tone. Audiological testing will be conducted in collaboration with the National Centre for Audiology (London, ON) to ensure that the most accurate and relevant metrics are applied.

Gender: All

Ages: 18 Years - Any

Updated: 2026-08-18

1 state

Hearing Loss, Sensorineural
Cochlear Implants
COMPLETED

NCT04427033

The BCI 602 BONEBRIDGE Post-Market Clinical Follow-up Study

The Bonebridge system using the BCI 601 is marketed since 2012. Previous prospective, multi-center, non-randomized studies on the BCI 601 Bonebridge performed in adult and paediatric populations have shown a significant improvement in terms of aided sound field (SF) thresholds, word recognition scores (WRS), speech reception thresholds (SRT) and subjective device satisfaction. Safety was established by stable residual hearing and low complication rates. The Bonebridge, implanted in over 600 clinics worldwide, is the world's first active transcutaneous bone conduction implant (BCI) system. This study now focuses on the further developed BCI 602 (marketed since 2019) that has the same indication criteria and performance characteristics. The aim of this post-market clinical follow-up (PMCF) study is to provide clinical data for the long-term performance and safety when implanted with the Bonebridge BCI 602 .

Gender: All

Ages: 5 Years - Any

Updated: 2026-08-17

Hearing Loss
Hearing Loss, Conductive
Hearing Loss, Mixed
+3
COMPLETED

NCT06106373

iotaSOFT Pediatric Study

Prospective, non-randomized, open-label study to evaluate the safety and efficacy of the iotaSOFT Insertion System when used to assist electrode array insertion during cochlear implant surgery in a pediatric population.

Gender: All

Ages: 9 Months - 12 Years

Updated: 2026-08-06

2 states

Hearing Loss, Sensorineural
Hearing Loss, Bilateral
Hearing Loss, Unilateral
COMPLETED

NCT06560918

Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids

This goal of this study is to learn if a new audiology treatment process called the self-efficacy-based auditory rehabilitation (SEBAR) can improve confidence and success with over-the-counter (OTC) hearing aids. The main questions it aims to answer are: * Can the SEBAR improve participants' confidence related to managing their over-the-counter hearing aids? * Can the SEBAR improve participants' willingness to adopt over-the-counter hearing aids, their satisfaction, quality of life, and their emotional state? Researchers will compare these outcomes of the SEBAR with and without wearing OTC hearing aids. Participants will: * Visit for one appointment to complete a few questionnaires without OTC hearing aids * Wear a pair of ITC hearing aids for a week and use an app to answer questions about their experiences * Visit for a second appointment to complete the same questionnaires with OTC hearing aids.

Gender: All

Ages: 18 Years - 85 Years

Updated: 2026-08-05

1 state

Hearing Loss, Sensorineural
COMPLETED

NCT05973669

MED-EL Remote Care Multi-Center Feasibility Study

MED-EL Remote Care is a way for MED-EL cochlear implant users to check their hearing and cochlear implant device from any location, without the need for a scheduled, in-person appointment with their audiologist. This study will assess the effectiveness, efficiencies, and useability of MED-EL Remote Care.

Gender: All

Updated: 2026-07-31

4 states

Hearing Loss, Sensorineural
Cochlear Implant
Cochlear Implant Recipients
+2
RECRUITING

NCT05215197

Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation

Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.

Gender: All

Updated: 2026-07-14

Hearing Loss, Sensorineural
ACTIVE NOT RECRUITING

NCT06370351

A Phase I/II Clinical Trial With SENS-501 in Children Suffering From Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations

This study intends to assess safety, tolerability, and efficacy of SENS-501 in children between the ages of 6-31 months with pre-lingual hearing loss due to a mutation in the Otoferlin gene.

Gender: All

Ages: 6 Months - 31 Months

Updated: 2026-07-08

OTOF Gene Mutation
DFNB9
Congenital Deafness
+5
COMPLETED

NCT03686046

Evaluation of an Open-source Speech-processing Platform

Determining acceptability and usability of a wearable open-source speech processing platform (Master Hearing Aid) developed for hearing-aid research

Gender: All

Ages: 30 Years - 90 Years

Updated: 2026-07-02

1 state

Hearing Loss, Sensorineural
COMPLETED

NCT07667140

Standard Post Market Clinical Follow-up (PMCF) Study WSA 2026

The purpose of the study is to follow-up on a released low-risk device as part of standard PMCF activities.

Gender: All

Ages: 18 Years - Any

Updated: 2026-06-24

1 state

Hearing Loss, Sensorineural
ACTIVE NOT RECRUITING

NCT06293482

Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population

This study aims to evaluate the safety and efficacy of cochlear implantation for adults with bilateral sensorineural hearing loss who currently do not meet the FDA-approved indications for cochlear implantation. Following cochlear implantation, participants will complete speech perception assessments and questionnaires over the course of seven visits.

Gender: All

Ages: 18 Years - Any

Updated: 2026-06-03

8 states

Hearing Loss, Sensorineural
Hearing Loss, Bilateral
ACTIVE NOT RECRUITING

NCT06642935

A Study to Explore Improved Features and a Simplified Treatment Approach for a Totally Implantable Cochlear Implant (TICI) Research System in Adults With Severe Hearing Loss

This clinical study will test a new investigational totally implanted cochlear implant system (TICI G2). The cochlear implant has an implantable microphone under the skin to detect speech and sound from the environment allowing hearing without the need of any external parts. This study will explore new ways to process the sound from the implanted microphone. The study will be conducted in adults with sensorineural hearing loss, a type of hearing loss caused by damage to the inner ear or auditory nerve. The study participants will undergo a series of tests that include testing their implant and their hearing. They will also complete questionnaires to see how they rate their hearing and overall general health.

Gender: All

Ages: 18 Years - Any

Updated: 2026-05-29

1 state

Hearing Loss, Bilateral or Unilateral
Hearing Loss, Sensorineural
Hearing Loss, Cochlear
WITHDRAWN

NCT06437054

Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss

This study is a prospective, randomized pilot study. To verify an efficacy/safety of the mixed drug injectable delivery vehicle for treating intractable hearing loss. Hearing test, endoscopy of tympanic membrane and CT scans will be conducted after intratympanic treatment for evaluation.

Gender: All

Ages: 19 Years - Any

Updated: 2026-05-22

Hearing Loss, Sensorineural
Hearing Loss, Sudden
Intratympanic Injection
ENROLLING BY INVITATION

NCT06962540

Understanding Individual Listening Strategies

The goal of this clinical trial is to learn if hearing aid settings that are customized to individual listening strategies result in better speech understanding than non-customized hearing aid settings. The main question it aims to answer is: Do customized hearing aid settings result in better speech understanding? Researchers will compare hearing aid settings that match individual listening strategy to a general setting. Participants will: Wear hearing aids for a 2-hour visit to our laboratory. Listen to some sentences in noise and repeat the sentences they hear, with two different hearing aid settings Listen to some sentences in noise and rate how understandable they think those sentences are, with two different hearing aid settings

Gender: All

Ages: 18 Years - 90 Years

Updated: 2026-05-04

1 state

Hearing Loss, Sensorineural